Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis

被引:2
|
作者
Bloem, Ada E. M. [1 ,2 ,3 ]
Dolk, Hanneke M. [2 ,3 ]
Wind, Anne E. [2 ,3 ]
van der Vis, Joanne J. [2 ,3 ,4 ]
Kampen, Maarten J. [2 ,3 ]
Custers, Jan W. H. [1 ]
Spruit, Martijn A. [5 ,6 ,7 ]
Veltkamp, Marcel [2 ,3 ,8 ]
机构
[1] Univ Appl Sci Utrecht, Inst Movement Studies, Fac Hlth Care, Utrecht, Netherlands
[2] St Antonius Hosp, Interstitial Lung Dis Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands
[3] European Reference Network Lung, Nieuwegein, Netherlands
[4] St Antonius Hosp, Dept Clin Chem, Nieuwegein, Netherlands
[5] CIRO, Dept Res & Dev, Horn, Netherlands
[6] Maastricht Univ Med Ctr MUMC, Dept Resp Med, Maastricht, Netherlands
[7] Fac Hlth Med & Life Sci, NUTRIM, Inst Nutr & Translat Res Metab, Maastricht, Netherlands
[8] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands
关键词
Idiopathic pulmonary fibrosis (IPF); 6-min walk test (6MWT); Functional exercise capacity; Prognostic; Physiotherapy; GAP (Gender-Age-Physiology) model; CLINICAL-PRACTICE; DISTANCE; SURVIVAL; STANDARDIZATION; PIRFENIDONE; MORTALITY; SOCIETY; UPDATE;
D O I
10.1016/j.rmed.2024.107862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care. Methods: This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP). Results: In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (>= 413 m), 6MWD %predicted (>= 83 %), SpO2-nadir (>= 86 %) and distance-saturation-product (>= 374 m%), with the best discriminative value for SpO2-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO2-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power. Conclusion: Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO2-nadir to the GAP model seems promising for use in clinical care of IPF patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Idiopathic pulmonary fibrosis - Prognostic value of changes in physiology and six-minute-walk test
    Flaherty, Kevin R.
    Andrei, Adin-Cristian
    Murray, Susan
    Fraley, Chris
    Colby, Thomas V.
    Travis, William D.
    Lama, Vibha
    Kazerooni, Ella A.
    Gross, Barry H.
    Toews, Galen B.
    Martinez, Fernando J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) : 803 - 809
  • [42] USING THE 6-MIN WALK TEST TO ASSESS EXERCISE CAPACITY IN PEOPLE WITH PULMONARY HYPERTENSION
    Spencer, L.
    Zafiropoulos, B.
    Denniss, W.
    Alison, J.
    Fowler, D.
    Celemajer, D.
    RESPIROLOGY, 2012, 17 : 74 - 74
  • [43] Prediction of maximal oxygen uptake from 6-min walk test in pulmonary hypertension
    Appenzeller, Paula
    Gautschi, Fiorenza
    Mueller, Julian
    Lichtblau, Mona
    Saxer, Stephanie
    Schneider, Simon R.
    Schwarz, Esther, I
    Ulrich, Silvia
    ERJ OPEN RESEARCH, 2022, 8 (02)
  • [44] Ventilatory Equivalent During 6-Min Walk Test In Stable COPD Patients
    Satake, M.
    Shioya, T.
    Takahashi, H.
    Sugawara, K.
    Kasai, C.
    Kiyokawa, N.
    Watanabe, T.
    Sato, S.
    Kawagoshi, A.
    Homma, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [45] Comparability of the 6-min walk test using different test configurations
    Konopka, Del N.
    Shook, Robin P.
    Kohut, Marian L.
    Tulp, Rosalie Vos
    Franke, Warren D.
    JOURNAL OF AGING AND PHYSICAL ACTIVITY, 2008, 16 (03) : 355 - 361
  • [46] The 6-min walk test is useful for assessing prognosis in stable, ambulatory patients
    Bryony M. Mearns
    Nature Reviews Cardiology, 2012, 9 (8) : 432 - 432
  • [47] Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies
    Naoki Mugii
    Fujiko Someya
    Rheumatology International, 2018, 38 : 1443 - 1448
  • [48] Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies
    Mugii, Naoki
    Someya, Fujiko
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (08) : 1443 - 1448
  • [49] Correlation between the 6-min walk test and exercise stress test
    Limsuwan, Alisa
    ACTA PAEDIATRICA, 2010, 99 (07) : 958 - 959
  • [50] Physiological responses to the 6-min walk test and incremental shuttle walk test in adults with non-cystic fibrosis bronchiectasis
    de Camargo, Anderson Alves
    Amaral, Tatiane Soares
    Rached, Samia Zahi
    Athanazio, Rodrigo Abensur
    Lanza, Fernanda de Cordoba
    Cukier, Alberto
    Arrabal Fernandes, Frederico Leon
    Fernandes Carvalho, Celso Ricardo
    Stelmach, Rafael
    Dal Corso, Simone
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42